Upcoming Events
KORF Grant Recipients
Make a Difference Get involved

Upcoming Events

DINNER GALA – FRIDAY, NOVEMBER 16, 2018

Our Mission

To increase awareness and fund research for the prevention, treatment, and cure of SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)–a rare and life-threatening disease–as well as all forms of ovarian cancer.

The Katie Oppo Research Fund is a 501c3 non-profit organization dedicated to raising funds to research the cause and prevention of SCCOHT and all forms of ovarian cancer. All proceeds go directly to the research fund and are granted to cancer research institutions and individual researchers. We do not offer salaries to any team members as we are staffed entirely by volunteers who are dedicated to our cause and the memory of Katie Oppo. We raise money through events such as the Katie Oppo Memorial Walk/Run (June), the Katie Oppo Research Fund Dinner Gala (November), Supporter Sponsored Events and donations from people like you!

Funds Granted to Date

$293,100

Past Events

Possible Warning Signs of Ovarian Cancer:

  • Persistent abdominal bloating or nausea
  • Changes in normal energy levels (fatigue)
  • Pain, pressure or tenderness in the pelvic area or lower back
  • Changes in appetite or bowel movements
  • Pressure to empty bladder, difficulty emptying bladder or change in frequency of urination
  • Pain during sex
  • Abnormal vaginal bleeding
  • Increased abdominal girth
  • Changes in menstruation

 

*See your gynecologist for regular check-ups or if you have one or many of the above symptoms

Latest Research

BRIEF COMMUNICATION

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

Petar Jelinic*, Jacob Ricca*, Elke Van Oudenhove, Narciso Olvera, Taha Merghoub, Douglas A. Levine*, Dmitriy Zamarin*

Affiliations of authors: Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY (PJ, EVO, NO, DAL); Department of Medicine (JR, DZ) and Ludwig Collaborative Laboratory (JR, TM, DZ), Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY

*Authors contributed equally to this work. Correspondence to: Dmitriy Zamarin, MD, Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065 (e-mail: zamarind@mskcc.org).

Read More

Past Dinner Gala Honoree’s

Our 2017 Honoree Dr Andrew Menzin, is the Chief of Gynecologic Oncology for Northwell Health’s Central Region and the Co-Lead for the Center of Excellence in Gynecologic Oncology at the Northwell Health Cancer Institute. He is a Professor of OBGYN at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

 

 

 

Dinner Gala Journal 2017

Our 2016 Honoree Dr. Vincent P. Vinciguerra was chosen for his contributions and leadership in the development of many oncology programs, cancer treatment control clinical trials, scientific development and accruals. As Principal Investigator of the North Shore University Hospital Community Clinical Oncology Program (CCOP), he was instrumental in providing a wide range of clinical trials in cancer treatment and control. 

Dinner Gala Journal 2016

Our 2015 Honoree Dr. Arena received his Bachelor of Science Degree from Fordham University and his Medical Degree from Cornell University Medical College. His internship and residency were carried out at New York Hospital/Memorial Hospital, after which Dr. Arena served as Chief Medical Resident and later as Hematology/Oncology Fellow at the Memorial Sloan-Kettering Cancer Center.

 

Dinner Gala Journal 2015

Latest news from our blog